Edmund V. Mickunas

Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.

Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA.

Control Delivery Systems Inc. designs, develops and manufactures drug delivery products. The products are designed to deliver precise quantities of drugs to difficult-to-treat areas of the body. The company was founded in 1991 and is headquartered in Watertown, MA.

Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI.

Seeing Medicines, Inc. is a preclinical-stage biotechnology company that develops regenerative medicine treatments to restore and maintain vision in people. The company is based in Arden, NC. Seeing Medicines was founded by Lucian Del Priore, Andrew Fowlie, Matthew Vincent, H. LeRoux Jooste, Edmund V. Mickunas. H. LeRoux Jooste has been the CEO since incorporation.